BioLife Solutions Inc (NASDAQ:BLFS) Stake Lifted by Granite Investment Partners LLC

Share on StockTwits

Granite Investment Partners LLC increased its stake in BioLife Solutions Inc (NASDAQ:BLFS) by 25.5% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 103,109 shares of the medical equipment provider’s stock after acquiring an additional 20,947 shares during the period. Granite Investment Partners LLC’s holdings in BioLife Solutions were worth $1,845,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Roubaix Capital LLC purchased a new position in BioLife Solutions in the first quarter worth $809,000. Vanguard Group Inc. grew its position in BioLife Solutions by 43.1% in the third quarter. Vanguard Group Inc. now owns 447,984 shares of the medical equipment provider’s stock worth $7,839,000 after acquiring an additional 134,869 shares in the last quarter. GSA Capital Partners LLP grew its position in BioLife Solutions by 21.1% in the fourth quarter. GSA Capital Partners LLP now owns 13,800 shares of the medical equipment provider’s stock worth $166,000 after acquiring an additional 2,400 shares in the last quarter. Janney Montgomery Scott LLC grew its position in BioLife Solutions by 7.3% in the fourth quarter. Janney Montgomery Scott LLC now owns 20,515 shares of the medical equipment provider’s stock worth $247,000 after acquiring an additional 1,400 shares in the last quarter. Finally, Laurion Capital Management LP grew its position in BioLife Solutions by 74.0% in the first quarter. Laurion Capital Management LP now owns 84,944 shares of the medical equipment provider’s stock worth $1,520,000 after acquiring an additional 36,136 shares in the last quarter. Institutional investors own 45.76% of the company’s stock.

BioLife Solutions stock traded down $0.10 during mid-day trading on Wednesday, hitting $17.47. The company’s stock had a trading volume of 2,480 shares, compared to its average volume of 160,413. The company has a quick ratio of 12.99, a current ratio of 14.50 and a debt-to-equity ratio of 0.02. The company has a market capitalization of $328.23 million, a PE ratio of 125.07 and a beta of 1.45. BioLife Solutions Inc has a 12 month low of $9.15 and a 12 month high of $26.35.

BioLife Solutions (NASDAQ:BLFS) last posted its quarterly earnings results on Thursday, May 9th. The medical equipment provider reported $0.03 earnings per share for the quarter, hitting the consensus estimate of $0.03. The business had revenue of $5.77 million during the quarter, compared to the consensus estimate of $5.67 million. BioLife Solutions had a net margin of 17.01% and a return on equity of 10.32%. As a group, equities analysts expect that BioLife Solutions Inc will post 0.13 earnings per share for the current fiscal year.

BLFS has been the subject of several research reports. ValuEngine upgraded shares of BioLife Solutions from a “buy” rating to a “strong-buy” rating in a research report on Thursday, February 28th. BidaskClub upgraded shares of BioLife Solutions from a “hold” rating to a “buy” rating in a research report on Friday, March 1st. Zacks Investment Research lowered shares of BioLife Solutions from a “buy” rating to a “hold” rating in a research report on Tuesday, March 12th. Finally, Northland Securities reiterated a “buy” rating and issued a $18.00 target price on shares of BioLife Solutions in a research report on Monday, May 13th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. BioLife Solutions has a consensus rating of “Buy” and an average target price of $17.80.

In other BioLife Solutions news, CEO Michael Rice sold 7,088 shares of the business’s stock in a transaction on Wednesday, April 10th. The shares were sold at an average price of $17.91, for a total value of $126,946.08. Following the completion of the sale, the chief executive officer now directly owns 182,102 shares of the company’s stock, valued at $3,261,446.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Walter Villiger sold 39,883 shares of the business’s stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $19.18, for a total transaction of $764,955.94. The disclosure for this sale can be found here. Insiders sold 159,699 shares of company stock valued at $2,867,214 over the last three months. 38.50% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: “BioLife Solutions Inc (NASDAQ:BLFS) Stake Lifted by Granite Investment Partners LLC” was reported by Week Herald and is owned by of Week Herald. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://weekherald.com/2019/06/12/biolife-solutions-inc-nasdaqblfs-stake-lifted-by-granite-investment-partners-llc.html.

BioLife Solutions Company Profile

BioLife Solutions, Inc develops, manufactures, and markets grade cell and tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced cell damage and death.

Recommended Story: The risks of owning bonds

Want to see what other hedge funds are holding BLFS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BioLife Solutions Inc (NASDAQ:BLFS).

Institutional Ownership by Quarter for BioLife Solutions (NASDAQ:BLFS)

Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.